FDA approval of Provention Bio’s Teplizumab could bring first disease-modifying therapy to type 1… EP News Bureau Nov 27, 2020 If Provention Bio’s rolling Biologic License Application (BLA) submission to the FDA for teplizumab is approved, teplizumab will…
